We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants
JSPRW

26 hedge funds and large institutions have $2.51M invested in Japer Therapeutics Warrants in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% less funds holding

Funds holding: 35 → 26 (-9)

50% less capital invested

Capital invested by funds: $4.99M → $2.51M (-$2.48M)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
26
Holders Change
-9
Holders Change %
-25.71%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
5
Closed
13
Calls
$378K
Puts
–
Net Calls
+$378K
Net Calls Change
+$86K

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$263K
2
SCM
Shaolin Capital Management
Florida
+$256K
3
KJHP
K.J. Harrison & Partners
Ontario, Canada
+$14.6K
4
BI
Bulldog Investors
New Jersey
+$2.38K
5
WAM
Wolverine Asset Management
Illinois
+$88

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$246K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$236K
3
BCM
Beryl Capital Management
California
-$183K
4
LIM
Longfellow Investment Management
Massachusetts
-$112K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$81K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$551K – – –
TCM
2
Tenor Capital Management
New York
$205K – – –
PSAMP
3
P. Schoenfeld Asset Management (PSAM)
New York
$195K – – –
SRCM
4
Sage Rock Capital Management
New York
$157K – – –
AA
5
AQR Arbitrage
Connecticut
$154K – – –
PMAM
6
Picton Mahoney Asset Management
Ontario, Canada
$153K – – –
UOC
7
UBS O'Connor
Illinois
$151K +$263K +179,723 New
SCM
8
Shaolin Capital Management
Florida
$143K +$256K +174,899 New
GCL
9
Glazer Capital LLC
New York
$137K – – –
ACM
10
Altium Capital Management
New York
$133K – – –
MS
11
Maven Securities
Jersey
$82K – – –
BI
12
Bulldog Investors
New Jersey
$75K +$2.38K +1,625 +2%
MIM
13
Monashee Investment Management
Massachusetts
$72K – – –
RCM
14
Rivernorth Capital Management
Florida
$54K – – –
LA
15
Linden Advisors
New York
$53K -$2.69K -1,841 -3%
AGM
16
Alpine Global Management
New York
$42K – – –
HF
17
HRT Financial
New York
$33K – – –
YCM
18
Yakira Capital Management
Connecticut
$31K -$5.7K -3,900 -9%
CCM
19
Context Capital Management
California
$21K – – –
CAPTRUST Financial Advisors
20
CAPTRUST Financial Advisors
North Carolina
$20K -$2.37K -1,617 -6%
OAC
21
OMERS Administration Corp
Ontario, Canada
$17K -$31K -21,200 -50%
ES
22
Equitec Specialists
Illinois
$11K -$22.9K -15,665 -54%
EIP
23
Easterly Investment Partners
Massachusetts
$8K – – –
KJHP
24
K.J. Harrison & Partners
Ontario, Canada
$8K +$14.6K +10,000 New
PAM
25
Panagora Asset Management
Massachusetts
$3K – – –
1
2

JSPRW Hedge Fund Activity: Q1 2021 in Review

26 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2021, worth a combined $2.51M — down 50% from $4.99M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of JSPRW and 4 opened new positions — a net loss of 9 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $263K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $246K sold.

  • 26 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2021, down from 35 in Q4 2020.
  • Funds reported $2.51M of Japer Therapeutics Warrants stock for Q1 2021, down 50% quarter-over-quarter.
  • 4 funds opened new Japer Therapeutics Warrants positions in Q1 2021 and 13 closed out, a net change of -9 holders.
  • The largest Japer Therapeutics Warrants buyer in Q1 2021 was UBS O'Connor, an estimated $263K added.
  • The largest Japer Therapeutics Warrants seller in Q1 2021 was Boothbay Fund Management, an estimated $246K sold.

Based on aggregated 13F filings for Q1 2021.